OC LIFe: Changing Tides, Headwinds, and Opportunities Facing Drug Development

Join ULP at OC LIFe for a discussion on how drug development strategies are evolving.

The rapid increase in drug development activity in recent years has resulted in regulatory efforts to modernize how new drug products are regulated through restructure, new guidance for advanced therapies and new laws like the FDA Modernization Act 2.0. These changes impact how drugs are developed and approved. Drug developers need to be aware of these changes and adjust their development strategies for novel therapeutics. Please join us for an interactive panel discussion where we will discuss how drug development strategies are evolving.

Create Connections that Could Last a Lifetime

The Orange County Lifesciences Innovators Forum (OC LIFe) is a monthly marquee event series focused on creating a collaborative environment that fosters connections between innovators in the life sciences and medtech industry.


The Park Club - inside The Monet Restaurant

650 Town Center Dr., Costa Mesa, CA 92626

Guest Valet parking is available for $12, with plenty of public parking in the Center Tower Parking Garage.

Event Schedule

5:00 PM Registration and Networking

5:30 PM Buffet Dinner

6:30 PM Panel Presentations and Discussion

7:30 PM Networking


$45 Early Bird (Non-ULP Member) - Ends June 7 at 5:00 PM PST

$75 General Admission (Non-ULP Member)

$35 ULP Members - ULP Members can find their promo code on the Community Portal


Event Speakers

Sam Chuang Photo-2

Sam Chuang

Senior Director, Scientific Advisory Services
Charles River Laboratories

Sam is the Senior Director of Scientific Advisory Services for Charles River Laboratories. With over 25 years of academic, biotechnology and nonclinical CRO experience, Sam provides scientific and regulatory guidance in developing research strategies at all stages of drug candidate development from early discovery and target validation up to pre-approval. He leads a team of seasoned scientists with extensive regulatory and scientific experience in drug development. He has experience across a wide range of drug modalities including small and large molecules, nucleotides, and advanced therapies.

Amritha Jaishankar

Amritha Jaishankar

Executive Director, Cell & Gene Therapy Center

Amritha is a forward-thinking executive with 20+ years of experience in healthcare transformation specifically in the fields of cell and gene therapy (CGT) and regenerative medicine. She shapes strategies, lead organizations, and bring stakeholders together with a clear goal in mind: to deliver cutting-edge therapies and cures to people around the world. Throughout her career as an executive director and advisor—and early work delving into the research—she's recognized the need for urgency in this industry. Innovation is essential to identify, develop, and create new treatments. But innovation by itself is not enough. Speed-to-market is critical, too. Lives are on the line. It's her purpose to fast-track these therapies to patients.

Emre Koyuncu Photo-2

Emre Koyuncu

CEO & Founder
Crescenta Biosciences Inc.

Dr. Koyuncu is the Founder and CEO of Crescenta Biosciences Inc., a preclinical stage drug discovery company focused on developing novel immunometabolic modulators for age-related diseases and cancer. He is a molecular biologist & virologist with deep expertise in drug discovery. The intellectual property he developed while he was working at Princeton University formed the basis of several successful startups including Kadmon Corporation and was licensed/optioned by companies including Merck. Prior to founding Crescenta, Dr. Koyuncu served as a Co-founder and Head of Biology at Evrys Bio. He received his PhD from Heinrich-Pette-Institute for Experimental Virology and Immunology, Hamburg, Germany and was a post-doctoral fellow at Princeton University.

Bradley Gordon

Bradley Gordon

President & CEO
Katmai Pharmaceuticals

Mr. Gordon currently serves as President and CEO of Katmai Pharmaceuticals, a CNS oncology-focused biotech founded by leading chemistry, tumor biology, and clinical researchers at UCLA. During his career, Mr. Gordon played pivotal roles in the startup and growth of four biopharmaceutical companies along with one of the leading life science industry organizations, BIOCOM California. Throughout his career he served in executive management positions responsible for planning, funding, launching, building, partnering, acquiring and exiting both VC-funded and public biotechs. These include start-up ventures that established early foundational technologies in the fields of human gene therapy, regulation of kinase and ligase gene transcription pathways, novel stem cell regenerative and biomaterial treatments, and oncogene-targeted therapeutics. He has executed a large and diverse range of equity, debt, in/out licensing, R&D partnering, and M&A transactions across major international pharmaceutical markets including the U.S., Europe, and Japan. In addition to his private sector work, Mr. Gordon co-founded and currently serves as board chairman for one of the largest life science strategic procurement organizations worldwide, Core at BIOCOM California, serving over 1,700 member companies at over 3,500 sites and generating over $850MM annual group purchasing volume.

Event Partners

NexCore Group Logo

NexCore Group is a national healthcare real estate investment and development company that focuses on acquiring, developing, owning and managing healthcare facilities including medical office buildings, wellness facilities, ambulatory surgery centers, single and multi-specialty physician buildings, life sciences facilities, seniors housing communities and transitional rehabilitation centers. NexCore has completed $4.7 billion in healthcare real estate transactions throughout 29 states, developed and acquired over 14.3 million square feet of healthcare properties across the country and currently manages over $2.9 billion of healthcare facilities spanning 7.3 million square feet. The company has been recognized repeatedly as one of the Top Healthcare Real Estate Developers in the U.S. by Modern Healthcare and HREI.


HATCHspaces ®, LLC is a Los Angeles-based real estate development platform focused on simplifying the process of scientific innovation by creating purpose-built life sciences facilities for companies emerging from academic and incubator networks. With properties in various regional submarkets, HATCHspaces’® mission is to deliver the life science community state-of-the-art lab facilities at varying scales, allowing regions to retain early-stage bioscience and biotechnology start-ups emerging from research environments.

InsperityLogo_HR-Difference-Tag_CMYK (1)-1

Our tagline, HR that Makes a Difference, defines what we do. It emphasizes that human resources is a key driver of growth and contributes to a business’s bottom line. This is what sets Insperity apart.

Insperity has a long history of improving the success equation of small and midsize businesses across the country – because when businesses succeed, communities prosper.

And in today’s changing business environment, it’s our privilege to take care of an organization’s most valuable asset: its people.

Event Details

Community Event

Wednesday, June 26, 2024

05:00 PM - 08:00 PM

Register Now

Upcoming Event

July 24, 2024
05:00 PM - 08:00 PM

OC LIFe: Opportunities in Pediatric Research, Medical Device Development and Innovation

Register Now

Apply for residency today

Do you have a great company in the bioscience or medtech industry? Do you need wet-lab and/or fabrication space to develop and test your product?


Other Events

July 25, 2024
05:00 PM - 08:00 PM

OC LIFe: Opportunities in Pediatric Research, Medical Device Development and Innovation

Register Now
August 6, 2024
04:00 PM - 07:30 PM

ROCK the Science

Register Now
August 13, 2024
04:00 PM - 07:30 PM

Pitch. Launch. Grow. Demo Day | Annual Pitch Competition | ULP

Register Now